Sage Therapeutics (NASDAQ:SAGE – Free Report) had its price target decreased by TD Cowen from $10.00 to $9.00 in a research note issued to investors on Thursday morning,Benzinga reports.
Several equities research analysts recently weighed in on the company. Mizuho dropped their price target on Sage Therapeutics from $18.00 to $16.00 and set a “neutral” rating on the stock in a ...
Barclays raised the firm’s price target on Sage Group (SGPYY) to 1,050 GBp from 970 GBp and keeps an Underweight rating on the shares. Unlock your investing potential with TipRanks Premium - Now ...
Morgan Stanley analyst Vikram Purohit lowered the firm’s price target on Sage Therapeutics (SAGE) to $9 from $11 and keeps an Equal Weight rating on the shares after its Q3 results last week.
JPMorgan analyst Toby Ogg raised the firm’s price target on Sage Group (SGPYY) to 1,350 GBp from 1,240 GBp and keeps an Overweight rating on the shares. Unlock your investing potential with ...